The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

Izan Chalen; María Mercedes Cobo; Bernardo Gutierrez; Andrés Carrazco-Montalvo; Patricio Ponce; Diego F. Cisneros-Heredia

doi:10.3390/life12030325

The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

Izan Chalen^*
, María Mercedes Cobo
, Bernardo Gutierrez
, Andrés Carrazco-Montalvo
, Patricio Ponce
, Diego F. Cisneros-Heredia^*

^*Autor correspondiente de este trabajo

University of Illinois at Urbana-Champaign
University of Oxford Medical Sciences Division
Universidad San Francisco de Quito
University of Oxford
Instituto Nacional de Investigación en Salud Pública

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

1 Cita (Scopus)

Resumen

The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

Idioma original	Inglés
Número de artículo	325
Publicación	Life
Volumen	12
N.º	3
DOI	https://doi.org/10.3390/life12030325
Estado	Publicada - mar. 2022

Acceder al documento

10.3390/life12030325

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{2358ded5f39246a6b565fd9fda9154ba,

title = "The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation",

abstract = "The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.",

keywords = "Biotechnology industry, Coronavirus, Diagnosis, Research and development",

author = "Izan Chalen and Cobo, \{Mar{\'i}a Mercedes\} and Bernardo Gutierrez and Andr{\'e}s Carrazco-Montalvo and Patricio Ponce and Cisneros-Heredia, \{Diego F.\}",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = mar,

doi = "10.3390/life12030325",

language = "Ingl{\'e}s",

volume = "12",

journal = "Life",

issn = "2075-1729",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

TY - JOUR

T1 - The Shortcomings of COVID-19 Testing in Ecuador

T2 - Time to Incentivize Research and Innovation

AU - Chalen, Izan

AU - Cobo, María Mercedes

AU - Gutierrez, Bernardo

AU - Carrazco-Montalvo, Andrés

AU - Ponce, Patricio

AU - Cisneros-Heredia, Diego F.

PY - 2022/3

Y1 - 2022/3

N2 - The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

AB - The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

KW - Biotechnology industry

KW - Coronavirus

KW - Diagnosis

KW - Research and development

UR - https://www.scopus.com/pages/publications/85125483589

U2 - 10.3390/life12030325

DO - 10.3390/life12030325

M3 - Artículo

AN - SCOPUS:85125483589

SN - 2075-1729

VL - 12

JO - Life

JF - Life

IS - 3

M1 - 325

ER -

The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

Resumen

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto